Clinical Trial Update: A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy and safety of PTP-001 (MOTYS™) in knee osteoarthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• PTP-001 (MOTYS™)

Snippet

Sponsor: Doron Therapeutics Inc. | Conditions: Knee Osteoarthritis | Phase 3 | Status: RECRUITING